- Home
- ARWR vs ARE Comparison
ARWR vs ARE Comparison
Compare ARWR & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | ARE |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 9.1B |
| IPO Year | 2009 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ARWR | ARE |
|---|---|---|
| Price | $64.60 | $52.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 11 |
| Target Price | ★ $81.50 | $58.78 |
| AVG Volume (30 Days) | ★ 2.7M | 1.9M |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 8.66% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | $16,142,321.00 | ★ $3,026,556,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.52 |
| P/E Ratio | $287.41 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.66 | $44.10 |
| 52 Week High | $76.76 | $105.14 |
Technical Indicators
Market Signals| Indicator | ARWR | ARE |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 44.95 |
| Support Level | $60.53 | $49.38 |
| Resistance Level | $65.59 | $54.45 |
| Average True Range (ATR) | 2.68 | 1.93 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 87.05 | 37.01 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.